FINNENCE ▪ THE WIRE FILE
THE WIRE · № 72090
SEC Filing■ Unclear/unknown
CRWD filed 4 on 2026-10-08
KINDSEC Filing
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 00:00 UTC
LAST UPDATE2026-10-08 00:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A Form 4 filing indicates insider transaction, which may signal confidence or liquidity needs.
Insider activity noted, direction unclear
CATALYST TO WATCH
Details of transaction
MAIN RISK
Could be routine and immaterial
FULL DISPATCH
CRWD (CIK 0001778564) filed a 4 on 2026-10-08.
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
SUBJECTCrowdStrike · CRWD
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→INFERENCEfilings generate company commentary
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
New Phase 3 trial: Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne — Sagimet Biosciences Inc.2026-10-07 12:00 UTC
→INFERENCEfilings generate company commentary
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
Phase 3 results posted: Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate — Grifols Biologicals, LLC2026-10-07 12:00 UTC
→INFERENCEfilings generate company commentary
Phase 3 results posted: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers — Sanofi2026-10-07 12:00 UTC
Phase 3 results posted: Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and Toddlers — Sanofi2026-10-07 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Shanghai Henlius Biotech2026-10-08 12:00 UTC
New Phase 3 trial: A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Shanghai Henlius Biotech2026-10-08 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo — Dermavon Holdings Limited2026-10-08 12:00 UTC
New Phase 3 trial: A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo — Dermavon Holdings Limited2026-10-08 12:00 UTC
→INFERENCEfilings generate company commentary
New Phase 3 trial: Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes — Amgen2026-10-08 12:00 UTC
New Phase 3 trial: Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes — Amgen2026-10-08 12:00 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.